Christopher Henninger
General Practice · Vista, CANPI 1710040134
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $2,396 of the $3,891 with a category attached, or 61.6%. 12 manufacturers reported payments, led by A-dec, Inc. at 59.1% of the total. Reporting peaked in 2022 at $1,214 and has fallen 83.0% since, to $207 in 2025. Among general practice clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $90.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- A-dec, Inc.$2K
- Salvin Dental Specialties, Inc.$326
- Nobel Biocare USA$285
- Straumann USA LLC$265
- Dentsply Sirona Inc$214
- Kerr Corporation$192
- plus $309 from 6 others
What the payments were for
- Food & beverage$1,39536%
- Education$1003%
- Gifts$2,39662%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| A-dec, Inc. | 13 | $2,301 |
| Salvin Dental Specialties, Inc. | 4 | $326 |
| Nobel Biocare USA | 9 | $285 |
| Straumann USA LLC | 3 | $265 |
| Dentsply Sirona Inc | 5 | $214 |
| Kerr Corporation | 2 | $192 |
| Envista Holdings Corporation | 2 | $187 |
| Neoss, Inc. | 1 | $59 |
| Henry Schein, Inc. | 1 | $22 |
| Zimvie Inc. | 1 | $14 |
| 3M Company | 1 | $14 |
| Implant Direct Sybron International LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOBELACTIVE$106
- ZIRCONIA ABUTMENT PREPARATION KIT$106
- FINISHING STRIPS$102
- CEREC$100
How this compares
$3,891 in reported general payments places this provider in the 95th percentile of 12,963 general practice providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 182 | $1,188 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $665 |
| Amoxicillin | 99 | $361 |
| Naproxen | 83 | $337 |
| Clindamycin Hcl | 30 | $280 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 24 | $187 |
Paid to pharmacies, not to this prescriber.
Other general practice in Vista
- Nathan LiLancaster$5.2M
- Milton McCollSan Jose$4.9M
- Frederic MollRedwood City$2.5M
- Bradley ChingUpland$1.4M
- Eric BrassTorrance$755K
- Marc GeissbergerGreenbrae$583K
- Robert CampbellLong Beach$501K
- Varo BoyerNorth Hills$482K
- Michael MiyasakiSacramento$464K
- Apolinar MadrigalCeres$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.